Get startedLog in
    Picture of Genmab A/S logo

    GMAB — Genmab A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Genmab Q2 Net Sales Of Darzalex At $4,207 Mln

    Picture of Genmab A/S logoGenmab A/S
    15/07/2026 11:33
    BRIEF-Genmab Q2 Net Sales Of Darzalex At $4,207 Mln
    July 15 (Reuters) - Genmab A/S GMAB.CO:
    • GENMAB ANNOUNCES NET SALES OF DARZALEX® (DARATUMUMAB) FOR SECOND QUARTER OF 2026
    • NET SALES OF DARZALEX IN Q2 OF 2026 TOTALED USD 4,207 MILLION
    • Q2 DARZALEX NET TRADE SALES WERE USD 2,435 MILLION IN U.S. AND USD 1,772 MILLION IN REST OF WORLD
    Source text: ID:nGNE4qF004
    Further company coverage: GMAB.CO

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Genmab A/S

    See all news